7Baggers
 Atara Biotherapeutics, Inc. Announces Reduction in Its Workforce  MarketScreener Wed, 12 Nov 2025 18:36:32 GMT
 Atara Biotherapeutics: Q3 Earnings Snapshot  San Antonio Express-News Wed, 12 Nov 2025 15:06:37 GMT
 Atara Biotherapeutics (ATRA) Exceeds Q3 Revenue Estimates  GuruFocus Wed, 12 Nov 2025 14:40:14 GMT
 Atara Biotherapeutics Q3 revenue beats estimates  MarketScreener Wed, 12 Nov 2025 14:09:17 GMT
 the technical signals behind (atra) that institutions follow  news.stocktradersdaily.com Mon, 10 Nov 2025 22:54:02 GMT
 atara biotherapeutics (atra) to release earnings on tuesday  MarketBeat Wed, 05 Nov 2025 16:04:12 GMT
 Atara Biotherapeutics (ATRA) Transfers Key FDA Application to Pi  GuruFocus Mon, 03 Nov 2025 15:20:53 GMT
 Pierre Fabre takes over tabelecleucel BLA from Atara Biotherapeutics  Investing.com Mon, 03 Nov 2025 08:00:00 GMT
 5 under-the-radar biotech stocks that could soar in 2026  Barchart.com Tue, 28 Oct 2025 11:30:02 GMT

Atara Biotherapeutics, Inc
(NASDAQ:ATRA) 

ATRA stock logo

Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr viru...

Founded: 2012
Full Time Employees: 429
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends